16.62

0.18% -0.03

After Hours: 17.36 0.74 +4.45%

Baxter International Inc (BAX)

Overview News Price History Option Chain Financials Why BAX Down? Discussions Forecast Stock Split Dividend History

Baxter International Inc stock is traded at $16.62, with a volume of 4.73M. It is down -0.18% in the last 24 hours and down -6.05% over the past month. Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Previous Close:

$16.65

Open:

$16.71

24h Volume:

4.73M

Relative Volume:

0.48

Market Cap:

$8.58B

Revenue:

$11.24B

Net Income/Loss:

$-900.00M

P/E Ratio:

-9.8987

EPS:

-1.679

Net Cash Flow:

$323.00M

1W Performance:

-1.07%

1M Performance:

-6.05%

6M Performance:

-27.42%

1Y Performance:

-41.97%

1-Day Range:

$16.38

$16.80

1-Week Range:

$16.31

$17.20

52-Week Range:

$15.73

$32.68

Baxter International Inc Stock (BAX) Company Profile

Name

Baxter International Inc

Sector

Healthcare (1110)

Industry

Medical Instruments & Supplies (58)

Phone

(224) 948-2000

Address

ONE BAXTER PARKWAY, DEERFIELD, IL

Employee

37,500

Twitter

@baxter_intl

Next Earnings Date

2024-11-08

Latest SEC Filings

BAX's Discussions on Twitter

Compare BAX vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BAX Baxter International Inc	16.62	8.60B	11.24B	-900.00M	323.00M	-1.679
ISRG Intuitive Surgical Inc	452.95	160.74B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	154.96	44.18B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	74.67	36.38B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	43.12	35.62B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	226.05	32.77B	5.40B	1.49B	1.78B	10.12

Baxter International Inc Stock (BAX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-31-25	Downgrade	Argus	Buy → Hold
Aug-04-25	Downgrade	Stifel	Buy → Hold
Aug-01-25	Downgrade	Goldman	Buy → Neutral
Feb-26-25	Resumed	Goldman	Buy
Feb-24-25	Upgrade	Argus	Hold → Buy
Feb-20-25	Resumed	Barclays	Overweight
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight
May-30-24	Initiated	Goldman	Neutral
May-10-24	Downgrade	TD Cowen	Buy → Hold
May-30-23	Resumed	Morgan Stanley	Equal-Weight
Mar-29-23	Initiated	UBS	Neutral
Jan-06-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-05-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-03-23	Downgrade	BofA Securities	Buy → Neutral
Dec-19-22	Downgrade	JP Morgan	Overweight → Neutral
Dec-15-22	Downgrade	Deutsche Bank	Buy → Hold
Dec-12-22	Downgrade	Citigroup	Buy → Neutral
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Hold
Jun-24-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-04-22	Downgrade	Goldman	Neutral → Sell
Mar-02-22	Resumed	BofA Securities	Buy
Feb-18-22	Reiterated	KeyBanc Capital Markets	Overweight
Feb-18-22	Reiterated	Morgan Stanley	Overweight
Feb-18-22	Reiterated	Raymond James	Outperform
Feb-18-22	Reiterated	Stifel	Buy
Feb-18-22	Reiterated	UBS	Neutral
Feb-18-22	Reiterated	Wells Fargo	Overweight
Feb-11-22	Initiated	Goldman	Neutral
Jan-07-22	Resumed	Citigroup	Buy
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-13-21	Upgrade	Cowen	Market Perform → Outperform
Sep-03-21	Upgrade	Barclays	Equal Weight → Overweight
May-25-21	Initiated	Barclays	Equal Weight
Jan-29-21	Downgrade	Piper Sandler	Overweight → Neutral
Jan-06-21	Downgrade	UBS	Buy → Neutral
Dec-15-20	Downgrade	Goldman	Buy → Neutral
Oct-01-20	Upgrade	Citigroup	Neutral → Buy
Sep-04-20	Downgrade	Argus	Buy → Hold
Jun-24-20	Initiated	Oppenheimer	Outperform
Mar-19-20	Upgrade	Stifel	Hold → Buy
Mar-18-20	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-05-20	Initiated	Citigroup	Neutral
Feb-13-20	Initiated	Goldman	Buy
Jan-02-20	Upgrade	Evercore ISI	In-line → Outperform
Dec-17-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-26-19	Initiated	KeyBanc Capital Markets	Sector Weight
Apr-08-19	Downgrade	Evercore ISI	Outperform → In-line
Jan-02-19	Upgrade	Citigroup	Neutral → Buy
Jan-02-19	Upgrade	Morgan Stanley	Underweight → Overweight
Nov-02-18	Upgrade	Argus	Hold → Buy
Oct-16-18	Initiated	Barclays	Underweight
May-17-18	Resumed	Piper Jaffray	Overweight
Feb-06-18	Reiterated	Citigroup	Neutral
Jan-03-18	Initiated	Evercore ISI	Outperform
Jan-03-18	Upgrade	Raymond James	Mkt Perform → Outperform

View All

Baxter International Inc Stock (BAX) Latest News

Apr 06, 2026

Fund Update: 3,614,465 BAXTER INTERNATIONAL (BAX) shares added to GREENHAVEN ASSOCIATES INC portfolio - Quiver Quantitative

Apr 06, 2026

Evercore ISI Group Lowers Price Target for Baxter International (BAX) to $22 | BAX Stock News - GuruFocus

Apr 06, 2026

Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings - Bioscience Association Manitoba

Apr 06, 2026

Evercore ISI Adjusts Baxter International Price Target to $22 From $23, Maintains Outperform Rating - marketscreener.com

Apr 06, 2026

Evercore Maintains Baxter International Inc(BAX.US) With Buy Rating, Cuts Target Price to $22 - 富途牛牛

Apr 06, 2026

Assessing Baxter (BAX) Valuation After Launch Of IV Verify Line Labeling System - simplywall.st

Apr 06, 2026

Apr 05, 2026

Aug PreEarnings: Can Baxter International Inc deliver alphaEarnings Miss & Reliable Price Breakout Signals - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026